Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative Colitis
PMID: 39660680
Source: Aliment Pharmacol Ther
Publication date:
2025-07-24
Year:
2025
Abstract
NULL